Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1571-1580 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|March 1, 1995
RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemiaC Taylor, H McGlynn, G Carter, et al.
Leukemia|June 1, 1993
Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessmentA Orazi, G Cattoretti, D Soligo, et al.
Leukemia|June 1, 1993
N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemiaE Coustan-Smith, F G Behm, C A Hurwitz, et al.
Leukemia|June 1, 1993
Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of diseaseM J Borowitz, A Weidner, E A Olsen, et al.
Leukemia|October 1, 1992
The effects of IL-1 beta and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cellsA J Wagteveld, M T Esselink, P Limburg, et al.
Leukemia|October 1, 1992
Interleukin 2 production and interleukin 2 receptor expression by human immature leukemic T cellsY Sahraoui, M Allouche, A Ammar, et al.
Leukemia|October 1, 1992
Inhibitory effects of AcSDKP on the mixed lymphocyte reaction (MLR). Part II. Human whole blood cellsC Lavignac, L Volkov, A Massé, et al.
Leukemia|October 1, 1992
Resistance circumvention strategies tested in clinical leukaemia specimens using the MTT colorimetric assayE Lambert, J K Rees, P R Twentyman
Leukemia|December 25, 2009
Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999M Tsuchida, A Ohara, A Manabe, et al.
Leukemia|December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008M Brüggemann, A Schrauder, T Raff, et al.
Pageof 963

Showing results (1571-1580 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|March 1, 1995
RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemiaC Taylor, H McGlynn, G Carter, et al.
Leukemia|June 1, 1993
Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessmentA Orazi, G Cattoretti, D Soligo, et al.
Leukemia|June 1, 1993
N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemiaE Coustan-Smith, F G Behm, C A Hurwitz, et al.
Leukemia|June 1, 1993
Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of diseaseM J Borowitz, A Weidner, E A Olsen, et al.
Leukemia|October 1, 1992
The effects of IL-1 beta and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cellsA J Wagteveld, M T Esselink, P Limburg, et al.
Leukemia|October 1, 1992
Interleukin 2 production and interleukin 2 receptor expression by human immature leukemic T cellsY Sahraoui, M Allouche, A Ammar, et al.
Leukemia|October 1, 1992
Inhibitory effects of AcSDKP on the mixed lymphocyte reaction (MLR). Part II. Human whole blood cellsC Lavignac, L Volkov, A Massé, et al.
Leukemia|October 1, 1992
Resistance circumvention strategies tested in clinical leukaemia specimens using the MTT colorimetric assayE Lambert, J K Rees, P R Twentyman
Leukemia|December 25, 2009
Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999M Tsuchida, A Ohara, A Manabe, et al.
Leukemia|December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008M Brüggemann, A Schrauder, T Raff, et al.
Pageof 963